Microarray glycoprofiling of CA125 improves differential diagnosis of ovarian cancer

Journal of Proteome Research

Volumn 12, Issue 3, 2013, Pages 1408-1418

  Chen, Kowa ^a   Gentry Maharaj, Aleksandra ^b   Burnell, Matthew ^b   Steentoft, Catharina ^a   Marcos Silva, Lara ^a,e   Mandel, Ulla ^a   Jacobs, Ian ^b,d   Dawnay, Anne ^c   Menon, Usha ^b   Blixt, Ola ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

antibody microarray; CA125; differential diagnosis; glycosylation; ovarian cancer

Indexed keywords

CA 125 ANTIGEN; MUCIN; MUCIN 1; MUCIN 16; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER CELL; CANCER PATIENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; GLYCOSYLATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OVARY CANCER; OVARY CARCINOMA; PELVIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 84874587039     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr3010474     Document Type: Article

References (58)

1. Brockhausen, I. Pathways of O-glycan biosynthesis in cancer cells Biochim. Biophys. Acta 1999, 1473 (1) 67-95
2. Campbell, S. Ovarian cancer: role of ultrasound in preoperative diagnosis and population screening Ultrasound Obstet. Gynecol. 2012, 40 (3) 245-54
3. RCOBG, Guidelines no. 34, Ovarian cysts in postmenopausal women. In Royal College of Obstetricians and Gynaecologists and the British Society of Urogynaecology; MRCOG: London, UK, 2003; pp 1-8.
4. Moore, R. G.; Maclaughlan, S. Current clinical use of biomarkers for epithelial ovarian cancer Curr. Opin. Oncol. 2010, 22 (5) 492-7
5. Skates, S. J.; Horick, N.; Yu, Y.; Xu, F. J.; Berchuck, A.; Havrilesky, L. J.; de Bruijn, H. W.; van der Zee, A. G.; Woolas, R. P.; Jacobs, I. J.; Zhang, Z.; Bast, R. C., Jr. Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions J. Clin. Oncol. 2004, 22 (20) 4059-66
6. Kulasingam, V.; Pavlou, M. P.; Diamandis, E. P. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer Nat. Rev. Cancer 2010, 10 (5) 371-8
7. Hogdall, C.; Fung, E. T.; Christensen, I. J.; Nedergaard, L.; Engelholm, S. A.; Petri, A. L.; Risum, S.; Lundvall, L.; Yip, C.; Pedersen, A. T.; Hartwell, D.; Lomas, L.; Hogdall, E. V. A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer Gynecol Oncol 2011, 123 (2) 308-13
8. Kadija, S.; Stefanovic, A.; Jeremic, K.; Radojevic, M. M.; Nikolic, L.; Markovic, I.; Atanackovic, J. The utility of human epididymal protein 4, cancer antigen 125, and risk for malignancy algorithm in ovarian cancer and endometriosis Int. J. Gynecol. Cancer 2012, 22 (2) 238-44
9. Jacobs, I.; Oram, D.; Fairbanks, J.; Turner, J.; Frost, C.; Grudzinskas, J. G. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer Br. J. Obstet. Gynaecol. 1990, 97 (10) 922-9
10. Geomini, P.; Kruitwagen, R.; Bremer, G. L.; Cnossen, J.; Mol, B. W. The accuracy of risk scores in predicting ovarian malignancy: a systematic review Obstet. Gynecol. 2009, 113 (2 Pt 1) 384-94
11. Karlsen, M. A.; Sandhu, N.; Hogdall, C.; Christensen, I. J.; Nedergaard, L.; Lundvall, L.; Engelholm, S. A.; Pedersen, A. T.; Hartwell, D.; Lydolph, M.; Laursen, I. A.; Hogdall, E. V. Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass Gynecol. Oncol. 2012, 127 (2) 379-83
12. Van Gorp, T.; Cadron, I.; Despierre, E.; Daemen, A.; Leunen, K.; Amant, F.; Timmerman, D.; De Moor, B.; Vergote, I. HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm Br. J. Cancer 2011, 104 (5) 863-70
13. Engelen, M. J.; Kos, H. E.; Willemse, P. H.; Aalders, J. G.; de Vries, E. G.; Schaapveld, M.; Otter, R.; van der Zee, A. G. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma Cancer 2006, 106 (3) 589-98
14. Giede, K. C.; Kieser, K.; Dodge, J.; Rosen, B. Who should operate on patients with ovarian cancer? An evidence-based review Gynecol. Oncol. 2005, 99 (2) 447-61
15. Kui Wong, N.; Easton, R. L.; Panico, M.; Sutton-Smith, M.; Morrison, J. C.; Lattanzio, F. A.; Morris, H. R.; Clark, G. F.; Dell, A.; Patankar, M. S. Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125 J. Biol. Chem. 2003, 278 (31) 28619-34
16. Kuno, A.; Uchiyama, N.; Koseki-Kuno, S.; Ebe, Y.; Takashima, S.; Yamada, M.; Hirabayashi, J. Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling Nat. Methods 2005, 2 (11) 851-6
17. Garcia, E.; Andrews, C.; Hua, J.; Kim, H. L.; Sukumaran, D. K.; Szyperski, T.; Odunsi, K. Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe J. Proteome Res. 2011, 10 (4) 1765-71
18. Saldova, R.; Wormald, M. R.; Dwek, R. A.; Rudd, P. M. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis Dis. Markers 2008, 25 (4-5) 219-32
19. Karlsson, N. G.; McGuckin, M. A. O-Linked glycome and proteome of high-molecular-mass proteins in human ovarian cancer ascites: Identification of sulfation, disialic acid and O-linked fucose Glycobiology 2012, 22 (7) 918-29
20. Bouanene, H.; Miled, A. Conflicting views on the molecular structure of the cancer antigen CA125/MUC16 Dis. Markers 2010, 28 (6) 385-94
21. Hattrup, C. L.; Gendler, S. J. Structure and function of the cell surface (tethered) mucins Annu. Rev. Physiol. 2008, 70, 431-57
22. Zhu, C. S.; Pinsky, P. F.; Cramer, D. W.; Ransohoff, D. F.; Hartge, P.; Pfeiffer, R. M.; Urban, N.; Mor, G.; Bast, R. C., Jr.; Moore, L. E.; Lokshin, A. E.; McIntosh, M. W.; Skates, S. J.; Vitonis, A.; Zhang, Z.; Ward, D. C.; Symanowski, J. T.; Lomakin, A.; Fung, E. T.; Sluss, P. M.; Scholler, N.; Lu, K. H.; Marrangoni, A. M.; Patriotis, C.; Srivastava, S.; Buys, S. S.; Berg, C. D. A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer Cancer Prev. Res. 2011, 4 (3) 375-83
23. Yue, T.; Maupin, K. A.; Fallon, B.; Li, L.; Partyka, K.; Anderson, M. A.; Brenner, D. E.; Kaul, K.; Zeh, H.; Moser, A. J.; Simeone, D. M.; Feng, Z.; Brand, R. E.; Haab, B. B. Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers PLoS One 2011, 6 (12) e29180
24. Leiserowitz, G. S.; Lebrilla, C.; Miyamoto, S.; An, H. J.; Duong, H.; Kirmiz, C.; Li, B.; Liu, H.; Lam, K. S. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int. J. Gynecol. Cancer 2008, 18 (3) 470-5
25. Walsh, C. S.; Karlan, B. Y. Molecular signatures of ovarian cancer: from detection to prognosis Mol. Diagn. Ther. 2010, 14 (1) 13-22
26. Akita, K.; Yoshida, S.; Ikehara, Y.; Shirakawa, S.; Toda, M.; Inoue, M.; Kitawaki, J.; Nakanishi, H.; Narimatsu, H.; Nakada, H. Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer Int. J. Gynecol. Cancer 2012, 22 (4) 531-8
27. Jankovic, M. M.; Milutinovic, B. S. Glycoforms of CA125 antigen as a possible cancer marker Cancer Biomark 2008, 4 (1) 35-42
28. Nolen, B. M.; Lokshin, A. E. Screening for ovarian cancer: old tools, new lessons Cancer Biomark 2010, 8 (4-5) 177-86
29. Balogun, N.; Gentry-Maharaj, A.; Wozniak, E. L.; Lim, A.; Ryan, A.; Ramus, S. J.; Ford, J.; Burnell, M.; Widschwendter, M.; Gessler, S. F.; Gayther, S. A.; Jacobs, I. J.; Menon, U. Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study J. Clin. Epidemiol. 2011, 64 (5) 525-30
30. Menon, U.; Gentry-Maharaj, A.; Ryan, A.; Sharma, A.; Burnell, M.; Hallett, R.; Lewis, S.; Lopez, A.; Godfrey, K.; Oram, D.; Herod, J.; Williamson, K.; Seif, M.; Scott, I.; Mould, T.; Woolas, R.; Murdoch, J.; Dobbs, S.; Amso, N.; Leeson, S.; Cruickshank, D.; McGuire, A.; Campbell, S.; Fallowfield, L.; Skates, S.; Parmar, M.; Jacobs, I. Recruitment to multicentre trials - lessons from UKCTOCS: descriptive study Br. Med. J. 2008, 337, a2079
31. Menon, U.; Gentry-Maharaj, A.; Hallett, R.; Ryan, A.; Burnell, M.; Sharma, A.; Lewis, S.; Davies, S.; Philpott, S.; Lopes, A.; Godfrey, K.; Oram, D.; Herod, J.; Williamson, K.; Seif, M. W.; Scott, I.; Mould, T.; Woolas, R.; Murdoch, J.; Dobbs, S.; Amso, N. N.; Leeson, S.; Cruickshank, D.; McGuire, A.; Campbell, S.; Fallowfield, L.; Singh, N.; Dawnay, A.; Skates, S. J.; Parmar, M.; Jacobs, I. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol. 2009, 10 (4) 327-40
32. Pepe, M. S.; Feng, Z.; Janes, H.; Bossuyt, P. M.; Potter, J. D. Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design J. Natl. Cancer Inst. 2008, 100 (20) 1432-8
33. Timms, J. F.; Cramer, R.; Camuzeaux, S.; Tiss, A.; Smith, C.; Burford, B.; Nouretdinov, I.; Devetyarov, D.; Gentry-Maharaj, A.; Ford, J.; Luo, Z.; Gammerman, A.; Menon, U.; Jacobs, I. Peptides generated ex vivo from serum proteins by tumor-specific exopeptidases are not useful biomarkers in ovarian cancer Clin. Chem. 2010, 56 (2) 262-71
34. Scholler, N.; Crawford, M.; Sato, A.; Drescher, C. W.; O'Briant, K. C.; Kiviat, N.; Anderson, G. L.; Urban, N. Bead-based ELISA for validation of ovarian cancer early detection markers Clin. Cancer Res. 2006, 12 (7 Pt 1) 2117-24
35. Blixt, O.; Head, S.; Mondala, T.; Scanlan, C.; Huflejt, M. E.; Alvarez, R.; Bryan, M. C.; Fazio, F.; Calarese, D.; Stevens, J.; Razi, N.; Stevens, D. J.; Skehel, J. J.; van Die, I.; Burton, D. R.; Wilson, I. A.; Cummings, R.; Bovin, N.; Wong, C. H.; Paulson, J. C. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (49) 17033-8
36. Burchell, J.; Taylor-Papadimitriou, J. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product Epithelial Cell Biol. 1993, 2 (4) 155-62
37. Steentoft, C.; Vakhrushev, S. Y.; Vester-Christensen, M. B.; Schjoldager, K. T.; Kong, Y.; Bennett, E. P.; Mandel, U.; Wandall, H.; Levery, S. B.; Clausen, H. Mining the O-glycoproteome using zinc-finger nuclease- glycoengineered SimpleCell lines Nat. Methods 2011, 8 (11) 977-82
38. Kusnezow, W.; Syagailo, Y. V.; Goychuk, I.; Hoheisel, J. D.; Wild, D. G. Antibody microarrays: the crucial impact of mass transport on assay kinetics and sensitivity Expert Rev. Mol. Diagn. 2006, 6 (1) 111-24
39. Price, M. R.; Rye, P. D.; Petrakou, E.; Murray, A.; Brady, K.; Imai, S.; Haga, S.; Kiyozuka, Y.; Schol, D.; Meulenbroek, M. F.; Snijdewint, F. G.; von Mensdorff-Pouilly, S.; Verstraeten, R. A.; Kenemans, P.; Blockzjil, A.; Nilsson, K.; Nilsson, O.; Reddish, M.; Suresh, M. R.; Koganty, R. R.; Fortier, S.; Baronic, L.; Berg, A.; Longenecker, M. B.; Hilgers, J. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996 Tumour Biol. 1998, 19 (Suppl 1) 1-20
40. DeLong, E. R.; DeLong, D. M.; Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 1988, 44 (3) 837-45
41. Aryal, R. P.; Ju, T.; Cummings, R. D. The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase J. Biol. Chem. 2010, 285 (4) 2456-62
42. Schietinger, A.; Philip, M.; Yoshida, B. A.; Azadi, P.; Liu, H.; Meredith, S. C.; Schreiber, H. A mutant chaperone converts a wild-type protein into a tumor-specific antigen Science 2006, 314 (5797) 304-8
43. Blixt, O.; Bueti, D.; Burford, B.; Allen, D.; Julien, S.; Hollingsworth, M.; Gammerman, A.; Fentiman, I.; Taylor-Papadimitriou, J.; Burchell, J. M. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis Breast Cancer Res. 2011, 13 (2) R25
44. Backstrom, M.; Link, T.; Olson, F. J.; Karlsson, H.; Graham, R.; Picco, G.; Burchell, J.; Taylor-Papadimitriou, J.; Noll, T.; Hansson, G. C. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells Biochem. J. 2003, 376 (Pt 3) 677-86
45. Wandall, H. H.; Blixt, O.; Tarp, M. A.; Pedersen, J. W.; Bennett, E. P.; Mandel, U.; Ragupathi, G.; Livingston, P. O.; Hollingsworth, M. A.; Taylor-Papadimitriou, J.; Burchell, J.; Clausen, H. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes Cancer Res. 2010, 70 (4) 1306-13
46. Wahrenbrock, M. G.; Varki, A. Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the ″tip of the iceberg″? Cancer Res. 2006, 66 (4) 2433-41
47. Stimpfl, M.; Schmid, B. C.; Schiebel, I.; Tong, D.; Leodolter, S.; Obermair, A.; Zeillinger, R. Expression of mucins and cytokeratins in ovarian cancer cell lines Cancer Lett 1999, 145 (1-2) 133-41
48. Saeland, E.; Belo, A. I.; Mongera, S.; van Die, I.; Meijer, G. A.; van Kooyk, Y. Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients Int. J. Cancer 2012, 131 (1) 117-28
49. Adamczyk, B.; Tharmalingam, T.; Rudd, P. M. Glycans as cancer biomarkers Biochim. Biophys. Acta 2012, 1820 (9) 1347-53
50. Jeschke, U.; Wiest, I.; Schumacher, A. L.; Kupka, M.; Rack, B.; Stahn, R.; Karsten, U.; Mayr, D.; Friese, K.; Dian, D. Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab Anticancer Res. 2012, 32 (5) 2185-9
51. Pearce, C. L.; Templeman, C.; Rossing, M. A.; Lee, A.; Near, A. M.; Webb, P. M.; Nagle, C. M.; Doherty, J. A.; Cushing-Haugen, K. L.; Wicklund, K. G.; Chang-Claude, J.; Hein, R.; Lurie, G.; Wilkens, L. R.; Carney, M. E.; Goodman, M. T.; Moysich, K.; Kjaer, S. K.; Hogdall, E.; Jensen, A.; Goode, E. L.; Fridley, B. L.; Larson, M. C.; Schildkraut, J. M.; Palmieri, R. T.; Cramer, D. W.; Terry, K. L.; Vitonis, A. F.; Titus, L. J.; Ziogas, A.; Brewster, W.; Anton-Culver, H.; Gentry-Maharaj, A.; Ramus, S. J.; Anderson, A. R.; Brueggmann, D.; Fasching, P. A.; Gayther, S. A.; Huntsman, D. G.; Menon, U.; Ness, R. B.; Pike, M. C.; Risch, H.; Wu, A. H.; Berchuck, A. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies Lancet Oncol. 2012, 13 (4) 385-94
52. Huhtinen, K.; Suvitie, P.; Hiissa, J.; Junnila, J.; Huvila, J.; Kujari, H.; Setala, M.; Harkki, P.; Jalkanen, J.; Fraser, J.; Makinen, J.; Auranen, A.; Poutanen, M.; Perheentupa, A. Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts Br. J. Cancer 2009, 100 (8) 1315-9
53. Ju, T.; Otto, V. I.; Cummings, R. D. The Tn antigen-structural simplicity and biological complexity Angew. Chem., Int. Ed. 2011, 50 (8) 1770-91
54. Clausen, H.; Stroud, M.; Parker, J.; Springer, G.; Hakomori, S. Monoclonal antibodies directed to the blood group A associated structure, galactosyl-A: specificity and relation to the Thomsen-Friedenreich antigen Mol. Immunol. 1988, 25 (2) 199-204
55. Blixt, O.; I., B.; U., M., Glycan Microarray Analysis of Tumor-Associated Antibodies. In Anticarbohydrate Antibodies; Kosma, P., Ed.; Springer Verlag: New York, 2012.
56. Blixt, O.; Clo, E.; Nudelman, A. S.; Sørensen, K. K.; Clausen, T.; Wandall, H. H.; Livingston, P. O.; Clausen, H.; Jensen, K. J. A high-throughput O-glycopeptide discovery platform for seromic profiling J. Proteome Res. 2010, 9 (10) 5250-61
57. Blixt, O.; Allin, K.; Bohorov, O.; Liu, X.; Andersson-Sand, H.; Hoffmann, J.; Razi, N. Glycan microarrays for screening sialyltransferase specificities Glycoconj. J. 2008, 25 (1) 59-68
58. Chen, S.; LaRoche, T.; Hamelinck, D.; Bergsma, D.; Brenner, D.; Simeone, D.; Brand, R. E.; Haab, B. B. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays Nat. Methods 2007, 4 (5) 437-44